The Hematologic Response to Anti-apoptotic Cytokine Therapy: Results of Pentoxifylline, Ciprofloxacin, and Dexamethasone Treatment for Patients with Myelodysplastic Syndrome

참고문헌 (Reference)

1 "World Health Organizationclassification of neoplastic diseases of the hematopoietic and lymphoidtissues:report of the Clinical Advisory Committee meeting-AirlieHouse,Virginia,November 1997" 17 : 3835-3849, 1999

2 "World Health Organization (WHO)international working group. Report of an international working group to standardize response criteria for myelodysplastic syndromes" 96 : 3671-3674,

3 "The suppressive influences of humantumor necrosis factors on bone marrow hematopoietic progenitorcells from normal donors and patients with leukemia effects of tumor necrosisfactor on the growth of erythroid progenitors CFU-E and BFUEand the hematopoietic cell lines K562" 928-35, jimmunol1986exphematol1987

4 "Thalidomide produces transfusion independence in longstandingrefractory anemias of patients with myelodysplastic syndromes" 98 : 958-965, 2001

5 "Stimulation of hematopoiesis by amifostine in patientswith myelodysplastic syndrome" 90 : 3364-3369, 1997

6 "Soluble TNF receptor fusion protein(etanercept) for the treatment of myelodysplastic syndrome: a pilotstudy" 16 : 162-164, 2002

7 "Remicade as TNF suppressor in patients with myelodysplastic syndromes" 45 : 2099-2104, 2004

8 "Randomizedcontrolled trial of azacitidine in patients with the myelodysplasticsyndrome a study of the cancer"

9 "Proposals for the classification of the myelodysplasticsyndromes" 51 : 189-99, 1982

10 "Pilot study of pentoxifylline andciprofloxacin with or without dexamethasone produces encouragingresults in myelodysplastic syndromes: acute leukemias VII" Springer-Verlag 42-51, 1998

11 "Phase II study of R115777, a farnesyl transferaseinhibitor, in myelodysplastic syndrome" 22 : 1287-1292, 2004

12 "Pentoxifylline, ciprofloxacin anddexamethasone improve the ineffective hematopoiesis in myelodysplasticsyndrome patients; malignancy" 5 : 275-284, 2000

13 "Patients with myelodysplastic syndromes benefit from palliativetherapy with amifostine, pentoxifylline, and ciprofloxacin withor without dexamethasone" 95 : 1580-1587, 2000

14 "OxidativeDNA damage in CD34+ myelodysplastic cells is associated withintracellular redox changes and elevated plasma tumour necrosisfactor-alpha concentration" 99 : 625-631, 1997

15 "Opportunities for Trisenox(arsenic trioxide)in the treatmentof myelodysplastic syndromes" 17 : 1499-1507, 2003

16 "Myelodysplasia" 340 : 1649-1660, 1999

17 "International scoring system for evaluating" 89 : 2079-2788, 1997

18 "Inhibition of human erythroid colony-formingunits by tumor necrosis factor requires beta interferon" 91 : 416-9, 1993

19 "Hematologic responses of patients with MDS to antithymocyteglobulin plus etanercept correlate with improved flow scoresof marrow cells" 28 : 1177-1180, 2004

20 "Expressionand modulation of cellular receptors for interferon-gamma,tumour necrosis factor, and Fas on human bone marrow CD34+cells" 97 : 356-365, 1997

21 "Expression of TNF receptorsand related signaling molecules in the bone marrow from patientswith myelodysplastic syndromes" 27 : 583-591, 2003

22 "Demethylation of a hypermethylatedP15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine(decitabine)treatment" 100 : 2957-2964, 2002

23 "Cytokines and MDS" 108 : 93-100, 2001

24 "Correlation of tumor necrosis factor alpha(TNFalpha)with high Caspase 3-like activity in myelodysplastic syndromes" 140 : 201-207, 1999

25 "Anti-TNF therapies in rheumatoid arthritis, Crohn’s disease,sepsis, and myelodysplastic syndromes." 50 : 229-235, 2000

26 "A role for tumour necro-sis factor-alpha, Fas and Fas-Ligand in marrow failure associatedwith myelodysplastic syndrome" 103 : 176-188, 1998

27 "A pilot study of the recombinant soluble humantumour necrosis factor receptor(p75)-Fc fusion protein in patientswith myelodysplastic syndrome" 117 : 119-126, 2002